JP4898447B2 - 結石破砕術の際の腎結石破片の閉じ込め - Google Patents
結石破砕術の際の腎結石破片の閉じ込め Download PDFInfo
- Publication number
- JP4898447B2 JP4898447B2 JP2006535581A JP2006535581A JP4898447B2 JP 4898447 B2 JP4898447 B2 JP 4898447B2 JP 2006535581 A JP2006535581 A JP 2006535581A JP 2006535581 A JP2006535581 A JP 2006535581A JP 4898447 B2 JP4898447 B2 JP 4898447B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- inverse
- calculus
- thermoresponsive polymer
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010029148 Nephrolithiasis Diseases 0.000 title claims description 25
- 208000000913 Kidney Calculi Diseases 0.000 title claims description 23
- 239000012634 fragment Substances 0.000 title description 6
- 239000004575 stone Substances 0.000 claims description 86
- 229920000208 temperature-responsive polymer Polymers 0.000 claims description 70
- 239000000203 mixture Substances 0.000 claims description 45
- 230000035939 shock Effects 0.000 claims description 39
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 38
- 229920001983 poloxamer Polymers 0.000 claims description 35
- 210000000626 ureter Anatomy 0.000 claims description 28
- 229920001987 poloxamine Polymers 0.000 claims description 25
- 210000003734 kidney Anatomy 0.000 claims description 22
- 229960000502 poloxamer Drugs 0.000 claims description 21
- 229920001992 poloxamer 407 Polymers 0.000 claims description 18
- 229920001400 block copolymer Polymers 0.000 claims description 16
- 230000007704 transition Effects 0.000 claims description 14
- 229940044476 poloxamer 407 Drugs 0.000 claims description 13
- 210000003932 urinary bladder Anatomy 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 210000000232 gallbladder Anatomy 0.000 claims description 11
- 210000000496 pancreas Anatomy 0.000 claims description 11
- 230000002441 reversible effect Effects 0.000 claims description 10
- 210000003079 salivary gland Anatomy 0.000 claims description 10
- 210000002429 large intestine Anatomy 0.000 claims description 9
- 210000000813 small intestine Anatomy 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229920002517 Poloxamer 338 Polymers 0.000 claims description 5
- 208000001130 gallstones Diseases 0.000 claims description 5
- 229920005605 branched copolymer Polymers 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 102000016997 Lithostathine Human genes 0.000 claims description 2
- 108010014691 Lithostathine Proteins 0.000 claims description 2
- 229910052768 actinide Inorganic materials 0.000 claims description 2
- 150000001255 actinides Chemical class 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 claims description 2
- 229920000578 graft copolymer Polymers 0.000 claims description 2
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 2
- 150000002602 lanthanoids Chemical class 0.000 claims description 2
- 229920005604 random copolymer Polymers 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 description 80
- 229920000642 polymer Polymers 0.000 description 60
- 239000000243 solution Substances 0.000 description 31
- 239000000499 gel Substances 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 238000009212 extracorporeal shock wave lithotripsy Methods 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- -1 oxides thereof Chemical compound 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 230000036760 body temperature Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 238000001879 gelation Methods 0.000 description 7
- 229920001451 polypropylene glycol Polymers 0.000 description 7
- 208000009911 Urinary Calculi Diseases 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 229920002359 Tetronic® Polymers 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 229920001993 poloxamer 188 Polymers 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000001883 cholelithiasis Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229940044519 poloxamer 188 Drugs 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000000451 tissue damage Effects 0.000 description 3
- 231100000827 tissue damage Toxicity 0.000 description 3
- 206010007027 Calculus urinary Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 238000002686 lithotriptor Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 229910052567 struvite Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 208000008281 urolithiasis Diseases 0.000 description 2
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAQCROVBDNBEEB-UBYUBLNFSA-N Metrizamide Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(=O)N[C@@H]2[C@H]([C@H](O)[C@@H](CO)OC2O)O)=C1I BAQCROVBDNBEEB-UBYUBLNFSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910004354 OF 20 W Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010038478 Renal lithiasis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000007682 dermal toxicity Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000011507 gypsum plaster Substances 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
- 229960004647 iopamidol Drugs 0.000 description 1
- 239000013541 low molecular weight contaminant Substances 0.000 description 1
- 239000013627 low molecular weight specie Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 229960000554 metrizamide Drugs 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 210000001581 salivary duct Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- SJOULNBNMIRTRG-UHFFFAOYSA-M sodium;3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoate Chemical compound [Na+].CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I SJOULNBNMIRTRG-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000007666 subchronic toxicity Effects 0.000 description 1
- 231100000195 subchronic toxicity Toxicity 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000009211 ultrasonic lithotripsy Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
- A61B17/12045—Type of occlusion temporary occlusion double occlusion, e.g. during anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/22022—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement using electric discharge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/26—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/008—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms using shock waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/12127—Double occlusion, e.g. for creating blood-free anastomosis site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
- A61B2017/22021—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter electric leads passing through the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B2017/22025—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement applying a shock wave
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22054—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation with two balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Electromagnetism (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Surgical Instruments (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51050503P | 2003-10-14 | 2003-10-14 | |
| US60/510,505 | 2003-10-14 | ||
| PCT/US2004/033517 WO2005037062A2 (en) | 2003-10-14 | 2004-10-12 | Confinement of kidney-stone fragments during lithotripsy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007508116A JP2007508116A (ja) | 2007-04-05 |
| JP2007508116A5 JP2007508116A5 (enExample) | 2007-11-22 |
| JP4898447B2 true JP4898447B2 (ja) | 2012-03-14 |
Family
ID=34465137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006535581A Expired - Fee Related JP4898447B2 (ja) | 2003-10-14 | 2004-10-12 | 結石破砕術の際の腎結石破片の閉じ込め |
Country Status (4)
| Country | Link |
|---|---|
| US (5) | US20050143678A1 (enExample) |
| EP (1) | EP1682014A4 (enExample) |
| JP (1) | JP4898447B2 (enExample) |
| WO (1) | WO2005037062A2 (enExample) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4898447B2 (ja) | 2003-10-14 | 2012-03-14 | プルーロームド インコーポレイテッド | 結石破砕術の際の腎結石破片の閉じ込め |
| US7883516B2 (en) * | 2004-07-07 | 2011-02-08 | Percutaneous Systems, Inc. | Methods for removing kidney stones from the ureter |
| US7972292B2 (en) | 2005-07-06 | 2011-07-05 | Percutaneous Systems, Inc. | Methods and apparatus for deploying ureteral stents |
| US7462183B2 (en) * | 2004-07-07 | 2008-12-09 | Percutaneous Systems, Inc. | Methods for deploying conformed structures in body lumens |
| US20060020269A1 (en) * | 2004-07-20 | 2006-01-26 | Eric Cheng | Device to aid in stone removal and laser lithotripsy |
| US20060135725A1 (en) * | 2004-12-21 | 2006-06-22 | Scimed Life Systems, Inc. | New balloon materials |
| US7907991B2 (en) * | 2005-03-02 | 2011-03-15 | C. R. Bard, Inc. | System and method for marking body cavities |
| PT2601972E (pt) * | 2005-05-02 | 2015-02-09 | Gen Hospital Corp | Tratamento de litíase renal sem litotripsia |
| US20070185520A1 (en) * | 2006-02-07 | 2007-08-09 | Boston Scientific Scimed, Inc. | Detachable medical immobilization device and related methods of use |
| US8062282B2 (en) * | 2006-02-13 | 2011-11-22 | Fossa Medical, Inc. | Methods and apparatus for temporarily occluding body openings |
| EP2034906A4 (en) | 2006-06-21 | 2010-07-28 | Univ Leland Stanford Junior | COMPOSITIONS AND METHODS FOR CONNECTING NON-ASSOCIATED LUMENS |
| US8197499B2 (en) * | 2006-06-21 | 2012-06-12 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
| US8608760B2 (en) | 2006-06-21 | 2013-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
| CN106236181A (zh) * | 2006-09-29 | 2016-12-21 | 普拉罗美德公司 | 碎石术期间预防结石和结石碎片后退的方法 |
| US8535250B2 (en) * | 2006-10-13 | 2013-09-17 | University Of Washington Through Its Center For Commercialization | Method and apparatus to detect the fragmentation of kidney stones by measuring acoustic scatter |
| US20080181952A1 (en) * | 2006-12-11 | 2008-07-31 | Pluromed, Inc. | Perfusive Organ Hemostasis |
| EP2219546B1 (en) * | 2007-11-29 | 2017-02-01 | Genzyme Corporation | Endoscopic mucosal resectioning using purified inverse thermosensitive polymers |
| BRPI0820785A2 (pt) * | 2007-12-20 | 2015-06-16 | Tautona Group L P | Composições e métodos para unir lúmens não unidos |
| US8563037B2 (en) * | 2009-02-06 | 2013-10-22 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
| US8845599B2 (en) | 2011-07-11 | 2014-09-30 | Boston Scientific Scimed, Inc. | Medical procedures, devices and kits for the formation and removal of plug-forming compositions |
| US9775674B2 (en) | 2011-09-10 | 2017-10-03 | Cook Medical Technologies Llc | Suction lithotripsy apparatus, method and kit |
| US9060886B2 (en) * | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
| AU2013246481B2 (en) | 2012-04-12 | 2016-06-09 | Boston Scientific Scimed, Inc. | Surgical laser systems and laser lithotripsy techniques |
| US20160184022A1 (en) * | 2013-03-13 | 2016-06-30 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
| US20160030070A1 (en) | 2013-03-14 | 2016-02-04 | The General Hospital Corporation | System and method for guided removal from an in vivo subject |
| US10406276B2 (en) * | 2013-03-14 | 2019-09-10 | The General Hospital Corporation | System and method for guided removal from an in vivo subject |
| US9360124B2 (en) | 2013-03-15 | 2016-06-07 | Cook Medical Technologies Llc | Bi-directional valve device for selective control of fluid flow through multiple converging paths |
| US9775631B2 (en) * | 2013-03-15 | 2017-10-03 | Boston Scientific Scimed, Inc. | Gel sweeper for residual stone fragment removal |
| EP2796101B1 (de) | 2013-04-23 | 2016-04-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten |
| EP2796100B1 (de) | 2013-04-23 | 2016-04-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Gelbildendes System zum Entfernen von Nierensteinfragmenten |
| DE202013012275U1 (de) | 2013-04-23 | 2015-12-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten |
| DE202013012287U1 (de) | 2013-04-23 | 2016-01-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Gelbildendes System zum Entfernen von Nierensteinfragmenten |
| US9282985B2 (en) | 2013-11-11 | 2016-03-15 | Gyrus Acmi, Inc. | Aiming beam detection for safe laser lithotripsy |
| US9636123B2 (en) * | 2014-03-21 | 2017-05-02 | Terumo Kabushiki Kaisha | Calculus retrieving/removing device and method |
| US9615842B2 (en) * | 2014-03-21 | 2017-04-11 | Terumo Kabushiki Kaisha | Calculus retrieving/removing device and method |
| US9610087B2 (en) * | 2014-03-21 | 2017-04-04 | Terumo Kabushiki Kaisha | Calculus retrieving/removing device and method |
| US9517080B2 (en) * | 2014-03-21 | 2016-12-13 | Terumo Kabushiki Kaisha | Calculus retrieving/removing device and method |
| US9539014B2 (en) * | 2014-03-21 | 2017-01-10 | Terumo Kabushiki Kaisha | Calculus removing/retrieving device and method |
| US9254075B2 (en) | 2014-05-04 | 2016-02-09 | Gyrus Acmi, Inc. | Location of fragments during lithotripsy |
| US9259231B2 (en) | 2014-05-11 | 2016-02-16 | Gyrus Acmi, Inc. | Computer aided image-based enhanced intracorporeal lithotripsy |
| US11246659B2 (en) * | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
| RU2661014C2 (ru) * | 2014-09-02 | 2018-07-11 | Нордсон Корпорейшн | Аппарат и способ для дробления минерально-органических конкрементов |
| US11058492B2 (en) * | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
| US9662097B2 (en) * | 2015-03-31 | 2017-05-30 | Terumo Kabushiki Kaisha | Method for retrieving objects from a living body and expanding a narrowed region in the living body |
| US9636127B2 (en) * | 2015-03-31 | 2017-05-02 | Terumo Kabushiki Kaisha | Method for retrieving objects from a living body |
| CN105147723B (zh) * | 2015-09-07 | 2018-05-08 | 山东赛克赛斯生物科技有限公司 | 一种温敏凝胶制剂、其制备方法及其在碎石术中防止结石转移中的应用 |
| CN106037864B (zh) * | 2016-07-21 | 2019-08-06 | 李勇 | 一种用于输尿管镜碎石术的可注射水凝胶封堵器 |
| EP3541442B1 (en) | 2016-11-16 | 2022-01-19 | Persica Pharmaceuticals Ltd. | Antibiotic formulations for lower back pain |
| TWI835758B (zh) * | 2017-11-16 | 2024-03-21 | 英商波西卡製藥公司 | 利奈唑胺(linezolid)調合物 |
| EP3746144B1 (en) | 2018-02-02 | 2025-12-03 | Calyxo, Inc. | Devices for minimally invasive kidney stone removal by combined aspiration and irrigation |
| US10799289B2 (en) | 2018-10-15 | 2020-10-13 | Avent, Inc. | Compositions, systems, kits, and methods for neural ablation |
| US11576744B2 (en) | 2021-03-25 | 2023-02-14 | The Regents Of The University Of California | Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stones |
| EP4101398B1 (de) | 2021-06-09 | 2025-03-05 | Purenum GmbH | Mehr-komponenten-zusammensetzung zur entfernung von partikeln |
| DE202021103106U1 (de) | 2021-06-09 | 2022-06-20 | Purenum Gmbh | Mehr-Komponenten-Zusammensetzung zur Entfernung von Partikeln |
| US12329396B2 (en) | 2022-03-02 | 2025-06-17 | Calyxo, Inc. | Kidney stone treatment system |
| US20240108412A1 (en) | 2022-09-29 | 2024-04-04 | Calyxo, Inc. | Tool guiding device for kidney stone treatment apparatus |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001521503A (ja) * | 1997-03-31 | 2001-11-06 | ネオルックス コーポレイション | 血管平滑筋細胞の治療的阻害物質 |
| JP2002521321A (ja) * | 1998-07-20 | 2002-07-16 | ラボラトワール エル.ラフォン | 放射線性粘膜炎及び化学剤性粘膜炎の予防及び治療のための医薬剤 |
| WO2002067788A1 (en) * | 2001-02-28 | 2002-09-06 | Scimed Life Systems, Inc. | Immobilizing objects in the body |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4308905A (en) * | 1980-03-24 | 1982-01-05 | Nancy Gallagher | Cover for air conditioner |
| US4608979A (en) * | 1984-02-22 | 1986-09-02 | Washington Research Foundation | Apparatus for the noninvasive shock fragmentation of renal calculi |
| JPS6116735A (ja) * | 1984-07-03 | 1986-01-24 | 京都府 | 結石破砕装置 |
| DE3506873A1 (de) * | 1985-02-27 | 1986-08-28 | Farco-Pharma GmbH, 5000 Köln | System zum auffangen von bruchstuecken, die anfallen beim zerkleinern von steinen in koerperhoehlen lebender menschen und warmbluetiger tiere |
| US4781677A (en) | 1985-07-17 | 1988-11-01 | Wilcox Gilbert M | Method of treatment utilizing a double balloon nasobiliary occlusion catheter |
| US5567859A (en) * | 1991-03-19 | 1996-10-22 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| US4845125A (en) | 1987-11-10 | 1989-07-04 | Indianapolis Center For Advanced Research, Inc. | Chemolytic EDTA-citric acid composition for dissolution of calculi |
| US4979948A (en) | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
| US5059200A (en) * | 1990-04-06 | 1991-10-22 | John Tulip | Laser lithotripsy |
| US5696298A (en) * | 1991-03-19 | 1997-12-09 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| CN1069741A (zh) | 1991-03-19 | 1993-03-10 | 西特克斯公司 | 具有改进的生物活性的聚氧丙烯/聚氧乙烯共聚物 |
| US5129910A (en) | 1991-07-26 | 1992-07-14 | The Regents Of The University Of California | Stone expulsion stent |
| DE69320136T3 (de) | 1992-05-11 | 2005-07-14 | Medical Innovations Corp., Draper | Verbesserter gallenkatheter |
| US5599300A (en) | 1992-05-11 | 1997-02-04 | Arrow Precision Products, Inc. | Method for electrosurgically obtaining access to the biliary tree with an adjustably positionable needle-knife |
| US5536248A (en) | 1992-05-11 | 1996-07-16 | Arrow Precision Products, Inc. | Method and apparatus for electrosurgically obtaining access to the biliary tree and placing a stent therein |
| US6770066B1 (en) | 1992-05-11 | 2004-08-03 | Ballard Medical Products | Multi-lumen endoscopic catheter |
| US5843028A (en) | 1992-05-11 | 1998-12-01 | Medical Innovations Corporation | Multi-lumen endoscopic catheter |
| US5401257A (en) | 1993-04-27 | 1995-03-28 | Boston Scientific Corporation | Ureteral stents, drainage tubes and the like |
| US5448363A (en) * | 1993-08-09 | 1995-09-05 | Hager; Horst | Food sorting by reflection of periodically scanned laser beam |
| US5531716A (en) | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
| JP3107488B2 (ja) | 1993-09-29 | 2000-11-06 | 株式会社資生堂 | 架橋ヒアルロン酸を用いた徐放性製剤及び塞栓剤 |
| US5403324A (en) * | 1994-01-14 | 1995-04-04 | Microsonic Engineering Devices Company, Inc. | Flexible catheter with stone basket and ultrasonic conductor |
| DE4405656C2 (de) * | 1994-02-22 | 1998-12-10 | Ferton Holding | Einrichtung zum Entfernen von Körpersteinen |
| US5860972A (en) * | 1995-10-26 | 1999-01-19 | Xintec Corporation | Method of detection and destruction of urinary calculi and similar structures |
| US5860872A (en) | 1996-03-07 | 1999-01-19 | Vitale; Kevin | Batter's stride training device |
| US5814006A (en) | 1996-05-28 | 1998-09-29 | Planz; Konrad | Temporary stent in the urine path |
| US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
| US5800711A (en) * | 1996-10-18 | 1998-09-01 | Mdv Technologies, Inc. | Process for the fractionation of polyoxyalkylene block copolymers |
| DE19881185C5 (de) * | 1997-08-22 | 2008-07-10 | Karl Storz Gmbh & Co. Kg | Vorrichtung zur Zertrümmerung von Konkrementen |
| WO1999023952A1 (en) | 1997-11-12 | 1999-05-20 | William Dubrul | Biological passageway occlusion removal |
| US6149656A (en) * | 1998-09-11 | 2000-11-21 | Volker Walz | Electrodynamic lithotriptor |
| US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
| US6375651B2 (en) | 1999-02-19 | 2002-04-23 | Scimed Life Systems, Inc. | Laser lithotripsy device with suction |
| US6159220A (en) | 1999-03-11 | 2000-12-12 | Scimed Life Systems, Inc. | Medical retrieval device |
| US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
| US7214229B2 (en) | 1999-03-18 | 2007-05-08 | Fossa Medical, Inc. | Radially expanding stents |
| US6214037B1 (en) | 1999-03-18 | 2001-04-10 | Fossa Industries, Llc | Radially expanding stent |
| US6620172B1 (en) | 1999-07-01 | 2003-09-16 | Medsource Technologies, Inc. | Entraining biological calculi |
| US6518871B2 (en) * | 1999-12-29 | 2003-02-11 | Robert B. Fennell | Fuseholder remover |
| US7039453B2 (en) | 2000-02-08 | 2006-05-02 | Tarun Mullick | Miniature ingestible capsule |
| US6440061B1 (en) | 2000-03-24 | 2002-08-27 | Donald E. Wenner | Laparoscopic instrument system for real-time biliary exploration and stone removal |
| US6761824B2 (en) * | 2000-08-17 | 2004-07-13 | Reeve Lorraine E | Process for the fractionation of polymers |
| US20040266983A1 (en) * | 2000-08-17 | 2004-12-30 | Reeve Lorraine E | Purified polyoxyalkylene block copolymers |
| US7041139B2 (en) | 2001-12-11 | 2006-05-09 | Boston Scientific Scimed, Inc. | Ureteral stents and related methods |
| AU2003211070A1 (en) * | 2002-02-15 | 2003-09-09 | Celsion Corporation | Method and apparatus treating tissue adjacent a bodily conduit with thermocompression and drugs |
| US6949125B2 (en) | 2002-04-16 | 2005-09-27 | Boston Scientific Scimed, Inc. | Ureteral stent with end-effector and related methods |
| DE10224352A1 (de) * | 2002-06-01 | 2003-12-11 | Mueller Schulte Detlef | Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie |
| JP4898447B2 (ja) | 2003-10-14 | 2012-03-14 | プルーロームド インコーポレイテッド | 結石破砕術の際の腎結石破片の閉じ込め |
| US7052489B2 (en) | 2003-12-05 | 2006-05-30 | Scimed Life Systems, Inc. | Medical device with deflecting shaft and related methods of manufacture and use |
| PT2601972E (pt) | 2005-05-02 | 2015-02-09 | Gen Hospital Corp | Tratamento de litíase renal sem litotripsia |
| EP1892231A1 (en) | 2006-08-21 | 2008-02-27 | Bayer Schering Pharma Aktiengesellschaft | A large scale method for the deoxofluorination of ketones |
-
2004
- 2004-10-12 JP JP2006535581A patent/JP4898447B2/ja not_active Expired - Fee Related
- 2004-10-12 WO PCT/US2004/033517 patent/WO2005037062A2/en not_active Ceased
- 2004-10-12 EP EP04794783A patent/EP1682014A4/en not_active Withdrawn
- 2004-10-12 US US10/963,410 patent/US20050143678A1/en not_active Abandoned
-
2010
- 2010-11-15 US US12/946,478 patent/US8409218B2/en not_active Expired - Lifetime
-
2013
- 2013-02-27 US US13/779,415 patent/US8998928B2/en not_active Expired - Lifetime
-
2015
- 2015-02-25 US US14/631,608 patent/US20160015393A1/en not_active Abandoned
-
2016
- 2016-05-09 US US15/149,885 patent/US20170086849A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001521503A (ja) * | 1997-03-31 | 2001-11-06 | ネオルックス コーポレイション | 血管平滑筋細胞の治療的阻害物質 |
| JP2002521321A (ja) * | 1998-07-20 | 2002-07-16 | ラボラトワール エル.ラフォン | 放射線性粘膜炎及び化学剤性粘膜炎の予防及び治療のための医薬剤 |
| WO2002067788A1 (en) * | 2001-02-28 | 2002-09-06 | Scimed Life Systems, Inc. | Immobilizing objects in the body |
Also Published As
| Publication number | Publication date |
|---|---|
| US20130172789A1 (en) | 2013-07-04 |
| US8409218B2 (en) | 2013-04-02 |
| US20160015393A1 (en) | 2016-01-21 |
| US20050143678A1 (en) | 2005-06-30 |
| EP1682014A4 (en) | 2010-11-17 |
| EP1682014A2 (en) | 2006-07-26 |
| US20170086849A1 (en) | 2017-03-30 |
| US8998928B2 (en) | 2015-04-07 |
| US20110060256A1 (en) | 2011-03-10 |
| WO2005037062A3 (en) | 2006-03-23 |
| JP2007508116A (ja) | 2007-04-05 |
| WO2005037062A2 (en) | 2005-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4898447B2 (ja) | 結石破砕術の際の腎結石破片の閉じ込め | |
| US7137966B2 (en) | Immobilizing objects in the body | |
| Garg et al. | Ureteroscopic laser lithotripsy versus ballistic lithotripsy for treatment of ureteric stones: a prospective comparative study | |
| Hofmann et al. | Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy | |
| GRASSO et al. | Principles and applications of laser lithotripsy: experience with the holmium laser lithotrite | |
| ES2458141T3 (es) | Terapia no litotrípsica de cálculos renales | |
| AU2002252121A1 (en) | Immobilizing objects in the body | |
| Dubosq et al. | Endoscopic lithotripsy and the FREDDY laser: initial experience | |
| Lulich et al. | Changing paradigms in the treatment of uroliths by lithotripsy | |
| Triantafyllidis et al. | Holmium laser lithothripsy of ureteral calculi: our initial experience | |
| Harmon et al. | Pediatric urolithiasis: review of research and current management | |
| Denstedt et al. | Intracorporeal lithotripsy with the Alexandrite laser | |
| US11576744B2 (en) | Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stones | |
| Picus | Intracorporeal biliary lithotripsy | |
| İLKER et al. | Ureteral extracorporeal shock wave lithotripsy utilizing Dornier MFL 5000 | |
| Zeltser et al. | Endoscopic management of ureteral stones | |
| Sacco et al. | Preventing migration of stones during fragmentation with thermosensitive polymer | |
| Bhandari et al. | Comparison of holmium laser and pneumatic lithotripsy in treatment of ureteral stones | |
| CA2623603C (en) | Immobilizing objects in the body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071001 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071001 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110315 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110615 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111129 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111226 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4898447 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150106 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |